MedTrace Logo

The Association Between Cognitive Function and Neuropathy in Individuals With Type 2 Diabetes

NCT06857994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2026-04-29

No results posted yet for this study

Summary

The goal of this observational study is to evaluate whether individuals with different types of diabetic neuropathy (peripheral and cardiovascular autonomic neuropathy) are at an increased risk of cognitive impairment and to investigate the potential reasons for this association.

The primary research question is: Is diabetic peripheral and cariovascular autonomic neuropathy in type 2 diabetes associated with cognitive decline?

To address this question, the study will include individuals with and without type 2 diabetes. All participants will undergo comprehensive neuropathy assessments, neuropsychological evaluations and blood biomarker analysis. In addition, some individuals will undergo structural and functional brain MRI.

Conditions

  • Peripheral Diabetic Neuropathy
  • Cardiovascular Autonomic Neuropathy
  • Cognitive Impairment
  • Diabetes Type 2

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Steno Diabetes Center Copenhagen

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-10
Primary Completion
2026-04-23
Completion
2026-04-23

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06857994 on ClinicalTrials.gov